Australian drug developer Biotron may have found a potential cure for Hepatitis C, after all patients who completed a trial of its lead antiviral drug emerged with undetectable levels of the virus.
Australian drug developer Biotron may have found a potential cure for Hepatitis C.
Biotron said on Friday that all patients who completed a phase II clinical trial of its lead antiviral drug, BIT225, had undetectable levels of Hepatitis C after ceasing all treatment.
